CClinicalTrials.gg
WithdrawnNCT00146263CogTrainUpdated Feb 27, 2020

Computerized Cognitive Training in the Elderly

An interventional study of Savyon and Control in Dementia, sponsored by Beersheva Mental Health Center. Withdrawn at 1 site in Israel. Open to participants aged 60 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2020-02-27.

Sponsored by Beersheva Mental Health Center · Not applicable, Interventional, and Treatment

Why this study was withdrawn
Difficulty in enrolling subjects in the proposed crossover study design
Phase
Not applicable
Study type
Interventional
Enrollment
0
Allocation
Randomized
Ages
60 Years and older
Sex
All
01

Study summary

Background:

The aging of the population has lead to a significant increase in the number of older people suffering from cognitive impairment and dementia. The present lack of effective drug therapy for these conditions makes it imperative to investigate other potential therapeutic interventions.

Cognitive training has been described as possibly useful in improving cognitive function in elderly subjects with mild impairment and early dementia. However, there have been few well-designed studies to date and the results are equivocal. Most studies have relied on the use of paper-based neuropsychological assessment instruments with limited accuracy and reproducibility. The investigators have developed a validated computerized neuropsychological assessment battery with increased test-retest reliability.

The purpose of this study is to assess the efficacy of a computerized training program on cognitive function in older persons with normal cognition, mild cognitive impairment, and early dementia.

Description:

A randomized prospective AB/BA crossover study.

Methods:

Eligible males and females aged 60 years and older following initial computerized neuropsychological assessment will be randomized to receive either a 12-session computerized cognitive training program, or no treatment. Repeat neuropsychological assessment will be followed by a 4-week no treatment phase, reassessment and crossover phase.

Read the detailed description

Background

In recent years there has been an increase in the elderly population. This fact has led to a significant number of people suffering from diseases which are associated with old age, amongst which is dementia.

The medical treatment of dementia is limited in its effectiveness and thus it is important to investigate other methods of therapy. One of the possible options to preserve the cognitive function is to apply cognitive exercise. If these exercises can improve cognitive expertise, it would open new vistas of treatment for dementia patients.

From a few research projects that have taken place on the subject, it has not been proved that cognitive exercising has been of use to patients suffering from mild dementia mainly because of methodological restraints. Thus it is necessary to undertake controlled random research on the subject.

The assessment of the cognitive state and the change in its status demands sensitive measurements. Objective and accurate computerized neuro-physiological testing like "Mindstream ®" and computer hardware are readably available. This technique enhances motivation and encourages participation.

Purpose of the work:

To evaluate the influence of computerized cognitive exercise on the cognitive function of the elderly suffering from mild dementia.

Methods:

IA randomized controlled study using a crossover AB/BA design will be performed. The intervention group will participate in a 12-session twice weekly intervention using the "Savyon" computerized cognitive training program (developed by the Melabev organization Jerusalem), which includes memory, language, arithmetic exercises and puzzles matching colors and shapes. The control group will continue with usual activities with no additional cognitive stimulation. Following a 4-week "washout" phase the groups will be switched in an AB/BA crossover design. A total of 150 subjects with mild cognitive impairment or early dementia will be included. Primary outcome measure will be the Mindstreams® (NeuroTrax Corp., N.Y.) computerized cognitive assessment battery performed initially, at 12 weeks, 16 weeks, 28 weeks.

For each Mindstreams ® index, the differences were compared the testing within each group utilizing "Wilcoxon Signed Ranks test" and between the groups utilizing "Mann-Whitney U test".

02

Conditions studied

  • Dementia

Browse trials for

Keywords

  • mild cognitive impairment
  • dementia
  • Alzheimer's Disease
  • cognitive training
03

In context

Dementia

2,172 studies on the registry are indexed under Dementia; 540 are open to participants now.

Browse Dementia studies →

Lead sponsor

Beersheva Mental Health Center is the lead sponsor of 24 studies on the registry; 2 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
60 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Age: above 60 years old

Exclusion criteria

Exclusion Criteria:

  • Visual impairment
  • Educational inability to perform training
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Crossover assignment
Masking
None (open label)
Enrollment
0 participants (actual)

Study arms

  • Active comparator
    Savyon

    Computerized cognitive training using the Savyon software

    Behavioral: Savyon

  • Placebo comparator
    Control

    Usual activity

    Behavioral: Control

Interventions

  • BehavioralSavyon

    Computerized cognitive training

  • BehavioralControl

    Usual activity

06

What researchers measure

Primary outcomes

  1. Computerized cognitive assessment using the Mindstreams battery

    Changes in cognitive function including memory, executive function, visual spatial and attention.

    Time frame: 12 weeks

07

Study locations

1 site
  • Beersheva Mental Health Center
    Beersheva, Israel
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 27, 2020, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT00146263
Lead sponsor
Beersheva Mental Health Center
Responsible party
Tzvi Dwolatzky (Principal Investigator, Beersheva Mental Health Center) — Principal investigator
First posted
Sep 7, 2005
Start date
Sep 2005
Primary completion
Dec 2007
Completion
Dec 2007
Last update
Feb 27, 2020

Study contacts

Tzvi Dwolatzky, MD
principal investigator · Ben-Gurion University of the Negev

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is withdrawn, as verified in Feb 2020. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion